BioCurex Inc. Obtains First Patent on Therapeutic Applications for Proprietary RECAF Marker

September 17, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

RICHMOND, BRITISH COLUMBIA--(Marketwire - September 17, 2008) - BioCurex Inc. (OTCBB: BOCX) today announced that the Australian Patent Office has issued a notice of acceptance for a divisional application of our original patent filing.

Twitter
LinkedIn
Facebook
Email
Print